| 1 | | Primary 26 Robinglade Dr | Toronto |  CA | | The Therapeutics & Nutrition Cooperation | N/A | N/A | N/A |
| 2 | | Primary Wagramer Straße 19 | Vienna |  AT | | Advancing Therapeutics. Improving Lives | N/A | Catia Lourenco | Receptionist |
| 3 | | Primary Spectrum Blvd | Tampa |  US | | Tinnitus and Hearing Disorder Therapeutics | N/A | Luisa Scott, PhD | Cognosetta Founder | Innovator | Science Communicator | Expert in CNS disorders |
| 4 | | Primary Via Borgogna, 5 | Milan |  IT | | First-In-Class Therapeutics For Autoimmune Disorders | N/A | Aurelia Ramunni | Executive Assistant at Enthera Pharmaceuticals |
| 5 | | Primary 94/H 9th Cross, 13th Main, RMV Extension, Sadashivanagar | Bangalore |  IN | | Telehealth Integrated Digital Therapeutics Platform | N/A | Kaif Salma | Senior Dietitian @7sugar.com |
| 6 | | Primary Parque Tecnológico de Cantanhede | Cantanhede |  PT | | Exosome-Based Therapeutics | N/A | Luisa Marques | Business Developer | Circular Economy Ambassador |
| 7 | | Primary | Cambridge | US | | Redefining Cancer Therapeutics | N/A | scott robinson | president and chief strategy officer |
| 8 | | Primary Kloosterstraat 9 RE0333/RE0207 | Oss |  NL | | Mrna Therapeutics | N/A | Ron Byron PhD | Ekoy Investment Partners -Teamwork makes the dream work (John Maxwell) |
| 9 | | Primary | San Francisco | US | | Transformative Therapeutics From Medicine's Roots | N/A | Ed Wiley, PhD | CTO | CIO | Data Science/Machine Learning Executive | Artificial Intelligence Expert | Board Advisor | Keynote Speaker |
| 10 | | Primary 35 CambridgePark Dr | Cambridge | US | | Leaders In Exosome Therapeutics | N/A | Aaron Noyes | Director at Codiak BioSciences |
| 11 | | Primary 155 Jefferson Dr | Menlo Park | US | | Gala Therapeutics | N/A | James Stambaugh | Senior Vice President, Clinical Affairs & Strategy at Gala Therapeutics |
| 12 | | Primary | San Diego | US | | A Next Generation Therapeutics Company | N/A | Brian Cajes | Head of Data and Engineering at Empirico Inc. |
| 13 | | Primary 200 Crescent Court Suite 455 | Dallas | US | | Hedge Fund Focused On Biotech/Pharma/Therapeutics | N/A | Neil Shahrestani, MD | Portfolio Manager - Biotech/Therapeutics |
| 14 | | Sinbuk-ro, Sinbuk-eup 61-20 | Gagnam-gu |  KR | | From Aesthetics To Therapeutics | N/A | Monica Kyong Ye Cho | HUGEL Head Of Legal/Compliance |
| 15 | | Primary | Heidelberg |  DE | | Digital Therapeutics | N/A | Abdullah Khalil | CTO at Midaia | Engineering Manager at Discovergy |
| 16 | | RENEURON PENCOED BUSINESS PARK | PENCOED |  GB | | Pioneering Stem Cell Therapeutics | N/A | olav hellebo | Chief Executive Officer |
| 17 | | Primary Avenida Tenente Valadim 17, 2F | Torres Vedras | PT | | Targeted Therapeutics | N/A | Raúl G. Saraiva, PhD | Biomedical Investment Manager at Portugal Ventures |
| 18 | | Primary | Sydney |  AU | | Advanced Therapeutics Within Everyone's Reach | N/A | Anthony Priyashantha Boteju | Head Of Marketing at Celltrion Healthcare Australia Pty Ltd |
| 19 | | Primary PO BOX 3008 Broadway Nedlands | Perth | AU | | Biosimilars, Biomarkers & Therapeutics | N/A | J. Chuck Morrison | Principle of Morrison and Associates |
| 20 | | RENEURON PENCOED BUSINESS PARK | PENCOED | GB | | Pioneering Stem Cell Therapeutics | N/A | Nicholas Adams | VP Business Development & Alliance Management at RENEURON GROUP PLC |
